The present invention is directed to acylguanidines which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPHl), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.
本发明涉及酰基
胍,它们是色
氨酸羟化酶(TPH)的
抑制剂,特别是isoform 1(TPHl),在治疗与外周
血清素有关的疾病或紊乱方面具有用处,例如胃肠道、心血管、肺部、炎症、代谢和骨量低等疾病,以及
血清素综合征和癌症。